Regeneron Stock – Alexion Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Shares of Alexion Pharmaceuticals Inc.
ALXN,
shed 0.69% to $152.35 Wednesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index
SPX,
rising 0.15% to 4,079.95 and the Dow Jones Industrial Average
DJIA,
rising 0.05% to 33,446.26. This was the stock’s second consecutive day of losses. Alexion Pharmaceuticals Inc. closed $10.25 short of its 52-week high ($162.60), which the company achieved on January 26th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Gilead Sciences Inc.
GILD,
fell 0.95% to $65.60, Vertex Pharmaceuticals Inc.
VRTX,
fell 1.20% to $212.72, and Regeneron Pharmaceuticals Inc.
REGN,
rose 0.65% to $481.79. Trading volume (1.7 M) remained 868,187 below its 50-day average volume of 2.5 M.
Editor’s Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.
Regeneron Stock – Alexion Pharmaceuticals Inc. stock outperforms competitors despite losses on the day
Tags: Regeneron Stock, NASDAQ: REGN, Regeneron Pharmaceuticals
Stock Market, Latest News on C N N.
